Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intercept Pharmaceuticals (NQ: ICPT )

13.70 +0.01 (+0.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 13.70
Bid (Size) 13.06 (1)
Ask (Size) 15.26 (1)
Prev. Close 13.69
Today's Range 13.70 - 13.70
52wk Range 10.81 - 21.86
Shares Outstanding 41,670,120
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Intercept Tumbles As Its Experimental NASH Drug Faces Yet Another Obstacle
Meanwhile, the company is facing a stout rival in the form of Madrigal Pharmaceuticals. 
Via Investor's Business Daily
Where Intercept Pharmaceuticals Stands With Analysts
 
Via Benzinga

Performance

YTD
+9.34%
+9.34%
1 Month
-29.64%
-29.64%
3 Month
+1.71%
+1.71%
6 Month
-10.10%
-10.10%
1 Year
-20.76%
-20.76%

More News

Read More
Preview: Intercept Pharmaceuticals's Earnings
Via Benzinga
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years
Via Investor's Business Daily
AT&T, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023
Via The Motley Fool
Analyst Ratings for Intercept Pharmaceuticals
Via Benzinga
Analyst Ratings for Intercept Pharmaceuticals
Via Benzinga
Expert Ratings for Intercept Pharmaceuticals
Via Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
What 6 Analyst Ratings Have To Say About Intercept Pharmaceuticals
Via Benzinga
Why Intercept Pharmaceuticals Stock Is Soaring Today
Via The Motley Fool
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
Via Investor's Business Daily
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Gartner, Sony, Uber And Other Big Gainers From Tuesday
Via Benzinga
Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday
Via Benzinga
Intercept Pharmaceuticals: Q3 Earnings Insights
Via Benzinga
Earnings Outlook For Intercept Pharmaceuticals
Via Benzinga
Citigroup To $47? Plus This Analysts Predict $95 For Papa John's
Via Benzinga
Wells Fargo To Surge Around 20%? Here Are 5 Other Price Target Changes For Monday
Via Benzinga
Nike, Lululemon, Dick's Sporting Goods And Other Big Losers From Friday
Via Benzinga
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday
Via Benzinga
Stocks Struggle For Direction As Choppy Q3 Comes To An End
Via Talk Markets
FUV Stock Alert: What Is Going on With Arcimoto Today?
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.